Creative Medical Technology Holdings, Inc. SEC filings CELZ
Creative Medical Technology Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Sep 13, 2002. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jul 14, 2026 | Aug 28, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 1, 2026 | Jul 1, 2026 |
| DEF 14A | Proxy statement | Nov 13, 2025 | Dec 26, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 3, 2025 | Nov 3, 2025 |
| DEF 14A | Proxy statement | Oct 30, 2025 | Oct 27, 2025 |
| DEF 14A | Proxy statement | Mar 17, 2025 | Mar 19, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 7, 2025 | Mar 7, 2025 |
| DEF 14A | Proxy statement | Nov 4, 2024 | Dec 19, 2024 |
| PRE 14A | Preliminary proxy statement | Oct 4, 2024 | Oct 4, 2024 |
| DEF 14A | Proxy statement | Jun 5, 2024 | Jul 19, 2024 |
| PRE 14A | Preliminary proxy statement | May 17, 2024 | Jul 19, 2024 |
| DEF 14A | Proxy statement | Nov 3, 2023 | Oct 31, 2023 |
| DEF 14A | Proxy statement | Oct 26, 2022 | Oct 25, 2022 |
| DEF 14C | Information statement | Sep 24, 2021 | Sep 20, 2021 |
| PRE 14C | Filing | Sep 7, 2021 | Sep 7, 2021 |
| DEF 14C | Information statement | Nov 22, 2019 | Nov 1, 2019 |
| PRE 14C | Filing | Nov 5, 2019 | Nov 5, 2019 |
| DEF 14C | Information statement | Sep 13, 2019 | Aug 26, 2019 |
| PRE 14C | Filing | Aug 30, 2019 | Aug 30, 2019 |
| DEF 14C | Information statement | Jan 31, 2018 | Jan 8, 2018 |
| PRE 14C | Filing | Jan 12, 2018 | Jan 12, 2018 |
| DEF 14C | Information statement | Jun 21, 2011 | Jun 21, 2011 |
| PRE 14C | Preliminary information statement | Jun 9, 2011 | Jun 9, 2011 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CELZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Phoenix, AZ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1187953
- Former names
- JOLLEY MARKETING INC (until May 13, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.